EUVIMEDEUVIMED entdecken
Crossref

Genetically engineered sericin hydrogels for the delivery of human adiponectin in treating ulcerative colitis in mice

Hongji Zhou, Yujuan Zhou, Hanxin Deng, Siyu Chen, Zihan Meng, Mengyao He, Ding Tu, He Wang, Xian Li, Fangyu Wang, Hexu Lei, Shifeng Yang und 4 weitere

Acta Biomaterialia · 2025

DOI: 10.1016/j.actbio.2025.07.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Hongji Zhou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Integrative Science Center of Germplasm Creation in Western China (CHONGQING) Science City, Biological Science Research Center, Southwest University,…. Hauptthemen laut MEDLINE: Hydrogels, Colitis, Ulcerative, Adiponectin, Sericins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Chongqing Municipal Science and Technology Bureau, Fundamental Research Funds for the Central Universities, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is one type of inflammatory bowel diseases, and adiponectin (APN) is a potential therapeutic protein drug for treating UC. However, source and targeted delivery of APN to improve its effectiveness and bioavailability remain challenges. Here, we report a strategy to develop a sericin hydrogel (rhAPN-sh) through genetically engineering silkworm to spin silks mixed with recombinant human adiponectin (rhAPN), which efficiently overcome APN source and delivery. The rhAPN-sh exhibits desirable material performances such as stable internal crystal structure, fast swelling behavior, good biocompatibility, injectability. The rhAPN-sh effectively protected the APN through harsh gastroenteric environment for oral administration, which alleviated UC symptoms in mice with significant therapeutic effect by reconstructing colonic cell structure and colon length, reducing release of inflammatory factors, and maintaining stability of intestinal microbial population. These results indicate that the fabricated rhAPN-sh is a promising system for colitis treatment. STATEMENT OF SIGNIFICANCE: The present study presents an efficient strategy to treat ulcerative colitis (UC) by developing a genetically engineered sericin hydrogel delivering recombinant human adiponectin (rhAPN). Using transgenic silkworms, the system enables efficient rhAPN production, while the sericin hydrogel protects APN from gastrointestinal degradation, ensuring effective oral delivery. The sericin hydrogel alleviates UC symptoms in mice by reducing inflammation, restoring colon structure, and maintaining gut microbiota stability. This approach overcomes key challenges in APN protein drug delivery, offering a scalable, biocompatible, and effective therapeutic platform for UC and potentially other inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsColitis, UlcerativeAdiponectinSericinsGenetic EngineeringDrug Delivery SystemsAnimalsHumansMiceRecombinant ProteinsBombyx

Stichwörter der Autor:innen

Oral administrationRecombinant human adiponectinSericin hydrogelTransgenic silkwormUlcerative colitis

Substanzen

HydrogelsAdiponectinSericinsRecombinant Proteins

Autor:innen und Institutionen

  • Integrative Science Center of Germplasm Creation in Western China (CHONGQING) Science City, Biological Science Research Center, Southwest University, Chongqing 400715, PR China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, Department of Radiology, West China Second University Hospital, Sichuan University, 20# South Renmin Road, Chengdu, Si…
  • Integrative Science Center of Germplasm Creation in Western China (CHONGQING) Science City, Biological Science Research Center, Southwest University, Chongqing 400715, PR China. Electronic address: wangf1986@swu.edu.cn.

Förderung

  • Chongqing Municipal Science and Technology Bureau
  • Fundamental Research Funds for the Central Universities
  • National Key Research and Development Program of China
  • Key Technologies Research and Development Program

Zitieren

APA

Zhou, H., Zhou, Y., Deng, H., Chen, S., Meng, Z., He, M., Tu, D., Wang, H., Li, X., Wang, F., Lei, H., Yang, S., Dong, H., Xia, Q., Li, X., & Wang, F. (2025). Genetically engineered sericin hydrogels for the delivery of human adiponectin in treating ulcerative colitis in mice. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2025.07.030

Vancouver

Zhou H, Zhou Y, Deng H, Chen S, Meng Z, He M, et al. Genetically engineered sericin hydrogels for the delivery of human adiponectin in treating ulcerative colitis in mice. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2025.07.030

BibTeX
@article{Zhou2025,
  author = {Zhou, Hongji and Zhou, Yujuan and Deng, Hanxin and Chen, Siyu and Meng, Zihan and He, Mengyao and Tu, Ding and Wang, He and Li, Xian and Wang, Fangyu and Lei, Hexu and Yang, Shifeng and Dong, Huan and Xia, Qingyou and Li, Xueming and Wang, Feng},
  title = {Genetically engineered sericin hydrogels for the delivery of human adiponectin in treating ulcerative colitis in mice},
  journal = {Acta Biomaterialia},
  year = {2025},
  doi = {10.1016/j.actbio.2025.07.030}
}
Kostenlos starten →